Literature DB >> 31559549

Glypican-1 as a Therapy Target in Esophageal Squamous Cell Carcinoma.

Qingcui Song1.   

Abstract

Entities:  

Year:  2019        PMID： 31559549     DOI： 10.1007/s10620-019-05852-8

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  5 in total

1.  Glypican-1 antisense transfection modulates TGF-beta-dependent signaling in Colo-357 pancreatic cancer cells.

Authors:  Junsheng Li; Jörg Kleeff; Hany Kayed; Klaus Felix; Roland Penzel; Markus W Büchler; Murray Korc; Helmut Friess
Journal:  Biochem Biophys Res Commun       Date:  2004-08-06       Impact factor: 3.575

2.  Correlation of glypican-1 expression with TGF-beta, BMP, and activin receptors in pancreatic ductal adenocarcinoma.

Authors:  Hany Kayed; Jörg Kleeff; Shereen Keleg; Xiaohua Jiang; Roland Penzel; Thomas Giese; Hanswalter Zentgraf; Markus W Büchler; Murray Korc; Helmut Friess
Journal:  Int J Oncol       Date:  2006-11       Impact factor: 5.650

3.  Glypican-1 Promotes Tumorigenesis by Regulating the PTEN/Akt/β-Catenin Signaling Pathway in Esophageal Squamous Cell Carcinoma.

Authors:  Jing Li; Yanjie Chen; Cheng Zhan; Jimin Zhu; Shuqiang Weng; Ling Dong; Taotao Liu; Xizhong Shen
Journal:  Dig Dis Sci       Date:  2019-02-07       Impact factor: 3.199

4.  Altering Glypican-1 levels modulates canonical Wnt signaling during trigeminal placode development.

Authors:  Celia E Shiau; Na Hu; Marianne Bronner-Fraser
Journal:  Dev Biol       Date:  2010-09-27       Impact factor: 3.582

5.  Glypican-1 regulates anaphase promoting complex/cyclosome substrates and cell cycle progression in endothelial cells.

Authors:  Dianhua Qiao; Xinhai Yang; Kristy Meyer; Andreas Friedl
Journal:  Mol Biol Cell       Date:  2008-04-16       Impact factor: 4.138
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.